50% of people in UK now aware of processed meat cancer risk
3/08/2016

World Cancer Research Fund has released 'encouraging' new statistics that show an increased number of British adults are now aware of the cancer risks attached to eating processed meat compared to...

Prostate cancer survival 'dependent on site disease spreads to'
3/08/2016

The survival time for men with metastatic prostate cancer depends on where the disease has spread to, with men whose cancer only spread to the lymph nodes faring best.

Prostate cancer survival 'dependent on site disease spreads to'
3/08/2016

The survival time for men with metastatic prostate cancer depends on where the disease has spread to, with men whose cancer only spread to the lymph nodes faring best.

High white blood cell ratio linked to recurrence risk in early stage breast cancer
3/07/2016

This might guide treatment and monitoring strategies, if prospective studies confirm link.

High white blood cell ratio linked to recurrence risk in early stage breast cancer
3/07/2016

This might guide treatment and monitoring strategies, if prospective studies confirm link.

Lung cancer screening: new Canadian guideline
3/07/2016

Adults aged 55-74 years who are at high risk of lung cancer - current or former smokers (i.e.

Lung cancer screening: new Canadian guideline
3/07/2016

Adults aged 55-74 years who are at high risk of lung cancer - current or former smokers (i.e.

Novel molecular processes controlling key genes in prostate cancer uncovered
3/07/2016

Researchers at Sweden's Karolinska Institutet and the University of Oulu in Finland have elucidated gene regulatory mechanisms that can explain how known genetic variants influence prostate cancer...

Novel molecular processes controlling key genes in prostate cancer uncovered
3/07/2016

Researchers at Sweden's Karolinska Institutet and the University of Oulu in Finland have elucidated gene regulatory mechanisms that can explain how known genetic variants influence prostate cancer...

Biofrontera announces full results of Phase III clinical trial evaluating BF-200 ALAfor treatment of basal cell carcinoma (BCC)
3/07/2016

Biofrontera AG, the specialist for suninduced skin cancer, has announced the full results of its Phase III clinical trial evaluating BF-200 ALA for the treatment of basal cell carcinoma (BCC) that...